| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |